Select Page
  1. Home
  2.  » 
  3. Catalent News
  4.  » Creating A Culture of Operational Excellence Presented at European Summit

SOMERSET, N.J., June 16, 2014 – Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, today announced that Mohammed Mazoir, Operational Excellence Manager, EU Sterile Operations, is to present “Developing and Sustaining a Process Excellence Culture” at the forthcoming Manufacturing Process Excellence Europe Summit (16-18 June 2014, Munich, Germany).

Mr. Mazoir’s presentation, scheduled for 5.30 pm on June 17th, will provide insight into how Catalent has developed and is sustaining a process excellence culture through sharing a clear vision, engaging and empowering its workforce, transforming culture and behavior through leadership, and building process excellence in teams and individuals. He will give examples of how simple, clear and consistent processes drive Catalent’s brand promise and its customers’ expectations to “Reliably Supply."

With over 18 years experience gained working in different industry sectors, including Automotive, Electronics, Flexible Packing and Consulting, in both operational and strategic roles, Mr. Mazoir has gained significant end-to-end experience in managing different aspects of continuous improvement, operational excellence and change management. At Catalent, he has responsibility for driving Operational Excellence in European Sterile Operations. Mr. Mazoir was awarded for the best industrial Lean Six Sigma project in France in 2011.

For more information on the Manufacturing PEX Europe Summit,visit: to arrange a meeting with Mr.Mazoir, contact Richard Kerns at Richard(at)NEPR(dot)eu.


Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2013 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit

More products. Better treatments. Reliably supplied.™